Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I

被引:46
作者
Biggar, RJ
Ng, J
Kim, N
Hisada, M
Li, HC
Cranston, B
Hanchard, B
Maloney, EM
机构
[1] NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20852 USA
[2] Res Triangle Inst, Rockville, MD USA
[3] Georgetown Univ, Dept Pediat, Washington, DC 20057 USA
[4] Univ W Indies, Kingston 7, Jamaica
关键词
D O I
10.1086/498910
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. We examined the association between mother-to-child human T cell lymphotropic virus type I (HTLV-I) transmission and human leukocyte antigen (HLA) class I types. Methods. In 1989, children born to HTLV-I-infected mothers in Jamaica were enrolled and prospectively evaluated for HTLV-I infection. HLA class I types in mothers and children were determined by DNA-based polymerase chain reaction methods. Associations between HLA class I types and transmission of HTLV-I were analyzed using proportional-hazards regression models adjusted for the duration of breast-feeding. Transmission risk in children still breast-feeding at 12 months was determined using actuarial methods. Results. Of 162 children, 28 (17%) became infected. After Bonferroni's adjustment for multiple comparisons, the transmission risk was not influenced by any specific HLA class type or the A2 supertype. However, compared with children who shared 3 HLA class I types with their mothers ( the minimum number possible), the transmission risk increased 1.8-fold with 4 shared types and 3.0-fold with 5 or 6 shared types (P-trend = .039; 1.75- fold increase for each additional concordant HLA type). This association was independent of maternal HTLV-I proviral level, antibody titer, and household income. Conclusions. We found a significant dose-response relationship between HTLV-I transmission via breast-feeding and mother-child HLA class I type concordance. Immunological interactions between a child's cells and maternal cells may influence the risk of HTLV-I infection by breast-feeding, perhaps because antigens on maternal cells are seen by the child as being "self."
引用
收藏
页码:277 / 282
页数:6
相关论文
共 29 条
[1]   Specific recognition of virus-infected cells by paired NK receptors [J].
Arase, H ;
Lanier, LL .
REVIEWS IN MEDICAL VIROLOGY, 2004, 14 (02) :83-93
[2]   The immune control and cell-to-cell spread of human T-lymphotropic virus type 1 [J].
Bangham, CRM .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :3177-3189
[3]  
Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834
[4]   Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples [J].
Dorak, MT ;
Tang, FM ;
Penman-Aguilar, A ;
Westfall, AO ;
Zulu, I ;
Lobashevsky, ES ;
Kancheya, NG ;
Schaen, MM ;
Allen, SA ;
Kaslow, RA .
LANCET, 2004, 363 (9427) :2137-2139
[5]   Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission [J].
Farquhar, C ;
Rowland-Jones, S ;
Mbori-Ngacha, D ;
Redman, M ;
Lohman, B ;
Slyker, J ;
Otieno, P ;
Obimbo, E ;
Rostron, T ;
Ochieng, J ;
Oyugi, J ;
Bosire, R ;
John-, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (07) :692-697
[6]  
HINO S, 1985, JPN J CANCER RES, V76, P474
[7]   Comments on the brief report "Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I" - Reply [J].
Hisada, M ;
Biggar, RJ ;
Li, HC ;
Hanchard, B .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (10) :1781-1781
[8]   Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica [J].
Hisada, M ;
Maloney, EM ;
Sawada, T ;
Miley, WJ ;
Palmer, P ;
Hanchard, B ;
Goedert, JJ ;
Manns, A .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) :1551-1557
[9]   Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton [J].
Igakura, T ;
Stinchcombe, JC ;
Goon, PKC ;
Taylor, GP ;
Weber, JN ;
Griffiths, GM ;
Tanaka, Y ;
Osame, M ;
Bangham, CRM .
SCIENCE, 2003, 299 (5613) :1713-1716
[10]  
Komatsu F, 1998, ONCOL RES, V10, P59